JUL 30, 2019 6:00 AM PDT

Overview of the new ERA Guidelines: Changes and Revisions

Sponsored by: Smithers
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Regulatory Affairs Scientist , Smithers Viscient
    Biography
      Dr. Erick Nfon is a Regulatory Scientist with particular experience in environmental fate modeling and regulatory affairs. Dr. Nfon has spent 14 years working in Academia, Industry and at European Contract Research Organizations and regulatory consultancies. His responsibilities include environmental risk assessments, dossier preparation and submission, and the provision of scientific expertise and advice to support registration programs for plant protection products, biocides, pharmaceuticals, and general industrial chemicals.

    Abstract
    DATE:  July 30, 2019
    TIME:   6:00am PT, 9:00am ET
     
    The current version of the EMA Guideline for the environmental risk assessment of human drugs was published in 2006. This guidance has now been revised ( a draft version was published on 15 November 2018 and is open for consultation until June 30, 2019).
     
    Amongst the notable changes are:
    • The introduction of a decision tree clarifying when ERA studies are required
    • The introduction of the term endocrine active substances to cover all substances that affect the development and/or reproduction
    • The introduction of guidance for the estimation of exposure to human pharmaceuticals via the food chain (secondary poisoning)
    • A revision to the tiered approach in testing
    • The introduction of tailored risk assessments for active substances with specific mode of action (e.g. antimicrobials and endocrine active substances) 
    Learning Objectives:
    • Understand revisions to EMA Guideline for the Environmental Risk Assessment of Human Drugs
    • Understand revision to the tiered approach to laboratory testing
    • Learn  about  “Endocrine Active Substances”
    • Understand tailored risk assessments for active substances with specific modes of action
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    Loading Comments...
    Show Resources
    Attendees
    • See more